# Weyerhaeuser Co: Form 10-K for the period ended Dec 31, 2023

- Company: [Weyerhaeuser Co](/companies/wy.md) (CIK 106535)
- Form: 10-K
- Filed: 2024-02-16
- Accepted by EDGAR: Feb 16, 2024, 16:31 ET
- Period: 2023-12-31
- Accession: 0000950170-24-016434
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/106535/000095017024016434/wy-20231231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/106535/000095017024016434/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2023-01-01 to 2023-12-31 | $7.67bn | us-gaap:Revenues |
| Cost of revenue | 12 months, 2023-01-01 to 2023-12-31 | $5.99bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months, 2023-01-01 to 2023-12-31 | $1.68bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2023-01-01 to 2023-12-31 | $7.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2023-01-01 to 2023-12-31 | $1.19bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2023-01-01 to 2023-12-31 | $280.0m | us-gaap:InterestExpense |
| Income tax | 12 months, 2023-01-01 to 2023-12-31 | $98.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2023-01-01 to 2023-12-31 | $839.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2023-01-01 to 2023-12-31 | $1.15 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2023-01-01 to 2023-12-31 | $1.15 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2023-01-01 to 2023-12-31 | 732,222,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2023-01-01 to 2023-12-31 | $1.43bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 12 months, 2023-01-01 to 2023-12-31 | $1.22bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months, 2023-01-01 to 2023-12-31 | $131.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2023-12-31 | $1.16bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2023-12-31 | $2.31bn | us-gaap:AssetsCurrent |
| Total assets | at 2023-12-31 | $16.98bn | us-gaap:Assets |
| Current liabilities | at 2023-12-31 | $788.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2023-12-31 | $6.75bn | us-gaap:Liabilities |
| Long-term debt | at 2023-12-31 | $5.07bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2023-12-31 | $0 | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2023-12-31 | $10.24bn | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/106535/000095017024016434/wy-20231231.htm

Filed Feb 16, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-016434. Last ingested by Listed: Oct 30, 2026, 16:24 ET. No prices; not investment advice.